Latest & greatest articles for otitis media

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on otitis media or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on otitis media and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for otitis media

101. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment

Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 NHS Economic Evaluation Database.

102. Otitis media. (Abstract)

Otitis media. Otitis media (OM) continues to be one of the most common childhood infections and is a major cause of morbidity in children. The pathogenesis of OM is multifactorial, involving the adaptive and native immune system, Eustachian-tube dysfunction, viral and bacterial load, and genetic and environmental factors. Initial observation seems to be suitable for many children with OM, but only if appropriate follow-up can be assured. In children younger than 2 years with a certain diagnosis

2004 Lancet

103. Pneumococcal vaccines for preventing otitis media. (Abstract)

Pneumococcal vaccines for preventing otitis media. Acute otitis media (AOM) is one of the most common diseases in early infancy and childhood. Long term effects of recurrent episodes of otitis media, rapid emergence of drug resistant bacteria associated with AOM worldwide and huge estimated direct and indirect annual costs associated with otitis media have emphasized the need for an effective vaccination program to prevent episodes of AOM.The object of this review was to assess the effect

2004 Cochrane

104. Adenoidectomy versus chemoprophylaxis and placebo for recurrent acute otitis media in children aged under 2 years: randomised controlled trial. Full Text available with Trip Pro

Adenoidectomy versus chemoprophylaxis and placebo for recurrent acute otitis media in children aged under 2 years: randomised controlled trial. To evaluate the efficacy of adenoidectomy compared with long term chemoprophylaxis and placebo in the prevention of recurrent acute otitis media in children aged between 10 months and 2 years.Randomised, double blind, controlled trial.Oulu University Hospital, a tertiary centre in Finland.180 children aged 10 months to 2 years with recurrent acute (...) otitis media.Adenoidectomy, sulfafurazole (sulphisoxazole) 50 mg/kg body weight, given once a day for six months or placebo. Follow up lasted for two years, during which time all symptoms and episodes of acute otitis media were recorded.Intervention failure (two episodes in two months or three in six months or persistent effusion) during follow up, number of episodes of acute otitis media, number of visits to a doctor because of any infection, and antibiotic prescriptions Number of prescriptions

2004 BMJ Controlled trial quality: predicted high

105. Screening children in the first four years of life to undergo early treatment for otitis media with effusion. (Abstract)

Screening children in the first four years of life to undergo early treatment for otitis media with effusion. Otitis media with effusion (OME) is the most common cause of acquired hearing loss in childhood and has been associated with delayed language development and behavioural problems. This condition has a prevalence of about 20% at the age of two years, a time of rapid language development. It is most often asymptomatic. Effective treatment exists for clearing effusions. Some have argued

2003 Cochrane

106. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. Full Text available with Trip Pro

Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. Acute otitis media (AOM) frequently complicates influenza infection. Previous studies have found influenza vaccine effective in reducing the occurrence of AOM in children mainly older than 2 years.To evaluate the effectiveness of inactivated influenza vaccine in preventing AOM in children aged 6 to 24 months.Randomized, double-blind, placebo-controlled trial of 786

2003 JAMA Controlled trial quality: predicted high

107. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. (Abstract)

Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Pneumococcal conjugate vaccine prevents recurrent acute otitis media (AOM) in infants immunised at 2, 4, 6, and 12-15 months of age. We aimed to find out whether this vaccine also prevents AOM in older children who have had previous episodes of AOM.In this double-blind, randomised study, we enrolled 383 patients aged 1-7 years who had had two or more (...) to the use of pneumococcal conjugate vaccine to prevent otitis media in previously unvaccinated toddlers and children with a history of recurrent AOM.

2003 Lancet Controlled trial quality: predicted high

108. Diagnosis, natural history, and late effects of otitis media with effusion

Diagnosis, natural history, and late effects of otitis media with effusion Diagnosis, natural history, and late effects of otitis media with effusion Diagnosis, natural history, and late effects of otitis media with effusion Shekelle P, Takata G, Chan L S, Mangione-Smith R, Corley PM, Morphew T, Morton S Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA (...) database. Citation Shekelle P, Takata G, Chan L S, Mangione-Smith R, Corley PM, Morphew T, Morton S. Diagnosis, natural history, and late effects of otitis media with effusion. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 55. 2003 Authors' objectives The purpose of this evidence-based report is to review the evidence on the natural history of otitis media with effusion (OME), the late effects of early life otitis media on hearing and speech

2003 Health Technology Assessment (HTA) Database.

109. Does this child have acute otitis media? Full Text available with Trip Pro

Does this child have acute otitis media? Does this child have acute otitis media? Does this child have acute otitis media? Rothman R, Owens T, Simel D L CRD summary This review assessed history taking and physical examination in the diagnosis of acute otitis media in children. The authors concluded that although many studies had methodological limitations, a cloudy, bulging or clearly immobile tympanic membrane is highly suggestive of acute otitis media. The conclusions were based on poor (...) -quality studies and may not be reliable. Authors' objectives To assess the precision and accuracy of history taking and physical examination in the diagnosis of acute otitis media (AOM) in children. Searching MEDLINE was searched from inception to May 2002 for studies published in English. The bibliographies of selected studies and general and specialist textbooks were also checked. Study selection Study designs of evaluations included in the review Studies that used a nonindependent comparison

2003 DARE.

110. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. (Abstract)

Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. Chronic otitis media with effusion (OME) has long been considered to be a sterile inflammatory process. The previous application of molecular diagnostic technologies to OME suggests that viable bacteria are present in complex communities known as mucosal biofilms; however, direct imaging evidence of mucosal biofilms associated with OM is lacking.To determine whether biofilm formation occurs in middle-ear (...) microscopy indicated that bacteria within the biofilms are viable.These preliminary findings provide evidence that mucosal biofilms form in an experimental model of otitis media and suggest that biofilm formation may be an important factor in the pathogenesis of chronic otitis media with effusion.

2002 JAMA

111. Pneumococcal vaccines for preventing otitis media. (Abstract)

Pneumococcal vaccines for preventing otitis media. Acute otitis media (AOM) is one of the most common diseases in early infancy and childhood. Long term effects of recurrent episodes of otitis media, rapid emergence of drug resistant bacteria associated with AOM worldwide and huge estimated direct and indirect annual costs associated with otitis media have emphasized the need for an effective vaccination program to prevent episodes of AOM.The object of this review was to assess the effect (...) in specific high-risk (otitis-prone) populations.

2002 Cochrane

112. Predictors of poor outcome and benefits from antibiotics in children with acute otitis media: pragmatic randomised trial. Full Text available with Trip Pro

Predictors of poor outcome and benefits from antibiotics in children with acute otitis media: pragmatic randomised trial. To identify which children with acute otitis media are at risk of poor outcome and to assess benefit from antibiotics in these children.Secondary analysis of randomised controlled trial cohort.Primary care.315 children aged 6 months to 10 years.Immediate or delayed (taken after 72 hours if necessary) antibiotics.Predictors of short term outcome: an episode of distress (...) was less likely with immediate antibiotics (32% for immediate v 53% for delayed, chi2=4.0; P=0.045, number needed to treat 5) as was night disturbance (26% v 59%, chi2=9.3; P=0.002; number needed to treat 3). In children without higher temperature or vomiting, immediate antibiotics made little difference to distress by day three (15% v 19%, chi2=0.74; P=0.39) or night disturbance (20% v 27%, chi2=1.6; P=0.20). Addition of cough did not significantly improve prediction of benefit.In children with otitis

2002 BMJ Controlled trial quality: predicted high

113. Ventilation tubes after surgery for otitis media with effusion or acute otitis media and swimming: systematic review and meta-analysis

Ventilation tubes after surgery for otitis media with effusion or acute otitis media and swimming: systematic review and meta-analysis Ventilation tubes after surgery for otitis media with effusion or acute otitis media and swimming: systematic review and meta-analysis Ventilation tubes after surgery for otitis media with effusion or acute otitis media and swimming: systematic review and meta-analysis Carbonell R, Ruiz-Garcia V Authors' objectives To determine whether swimming using ear (...) protection, swimming without ear protection and not swimming affects the risk of acute otitis media (AOM) in children with ventilation tubes. Searching MEDLINE (from 1966 to June 2001), EMBASE (from 1980 to June 2001) and the Cochrane Library (to June 2001) were searched without language restriction. In addition, the reference lists from identified studies were checked. Experts were not contacted and grey literature was not sought. A brief summary of the search strategy was reported in the review. Study

2002 DARE.

114. Decongestants and antihistamines for acute otitis media in children. (Abstract)

Decongestants and antihistamines for acute otitis media in children. Acute otitis media (AOM) is a common and important source of morbidity in children, although most cases resolve spontaneously. While frequently recommended, decongestant and antihistamine therapy is of unclear benefit.To determine the efficacy of decongestant and antihistamine therapy in children with AOM on outcomes of AOM resolution, medication side effects, and complications of AOM.Comprehensive search of Cochrane's

2001 Cochrane

115. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. Full Text available with Trip Pro

Efficacy of a pneumococcal conjugate vaccine against acute otitis media. Ear infections are a common cause of illness during the first two years of life. New conjugate vaccines may be able to prevent a substantial portion of cases of acute otitis media caused by Streptococcus pneumoniae.We enrolled 1662 infants in a randomized, double-blind efficacy trial of a heptavalent pneumococcal polysaccharide conjugate vaccine in which the carrier protein is the nontoxic diphtheria-toxin analogue CRM197 (...) . The children received either the study vaccine or a hepatitis B vaccine as a control at 2, 4, 6, and 12 months of age. The clinical diagnosis of acute otitis media was based on predefined criteria, and the bacteriologic diagnosis was based on a culture of middle-ear fluid obtained by myringotomy.Of the children who were enrolled, 95.1 percent completed the trial. With the pneumococcal vaccine, there were more local reactions than with the hepatitis B vaccine but fewer than with the combined whole-cell

2001 NEJM Controlled trial quality: predicted high

116. Effect of early or delayed insertion of tympanostomy tubes for persistent otitis media on developmental outcomes at the age of three years. (Abstract)

Effect of early or delayed insertion of tympanostomy tubes for persistent otitis media on developmental outcomes at the age of three years. A main indication for the insertion of tympanostomy tubes in infants and young children is persistent otitis media with effusion, reflecting concern that this condition may cause lasting impairments of speech, language, cognitive, and psychosocial development. However, evidence of such relations is inconclusive, and evidence is lacking that the insertion (...) +/-7 vs. 86+/-7); the General Cognitive Index of McCarthy Scales of Children's Abilities (99+/-14 vs. 101+/-13); or on measures of receptive language, sentence length, grammatical complexity, parent-child stress, and behavior.In children younger than three years of age who have persistent otitis media, prompt insertion of tympanostomy tubes does not measurably improve developmental outcomes at the age of three years.

2001 NEJM Controlled trial quality: uncertain

117. Effect of recolonisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial. Full Text available with Trip Pro

Effect of recolonisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial. To study the effect of recolonisation with alpha streptococci with the ability to inhibit the growth of otopathogens ("interfering" activity) on the recurrence of acute otitis media in susceptible children and the effect on the frequency of secretory otitis media.Double blind, randomised, placebo controlled study.Ear, nose (...) , and throat clinic with three doctors.130 children prone to otitis media aged between 6 months and 6 years, 108 of whom were eligible and followed for 3 months.Recurrence of otitis media during follow up and a normal tympanic membrane at the last valid visit.Children with no recurrences during the last month received phenoxymethylpenicillin (n=22), and those with a recurrence within 1 month received amoxicillin clavulanic acid (n=86), both twice daily for 10 days. These were followed by a streptococcal

2001 BMJ Controlled trial quality: predicted high

118. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. Full Text available with Trip Pro

Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. To compare immediate with delayed prescribing of antibiotics for acute otitis media.Open randomised controlled trial.General practices in south west England.315 children aged between 6 months and 10 years presenting with acute otitis media.Two treatment strategies, supported by standardised advice sheets-immediate antibiotics or delayed antibiotics (antibiotic prescription to be collected (...) mainly after first 24 hours, when symptoms were already resolving. For children who are not very unwell systemically, a wait and see approach seems feasible and acceptable to parents and should substantially reduce the use of antibiotics for acute otitis media.

2001 BMJ Controlled trial quality: predicted high

119. Management of acute otitis media

Management of acute otitis media Management of acute otitis media Management of acute otitis media Agency for Healthcare Research and Quality (AHRQ) Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Agency for Healthcare Research and Quality (AHRQ). Management of acute otitis media. Rockville: Agency for Healthcare Research and Quality (...) (AHRQ). Evidence Report/Technology Assessment No. 15. 2001 Authors' objectives The objective of this report is to analyze the evidence on the initial management of uncomplicated acute otitis media (AOM) in children. Authors' conclusions There is a wide range of reported clinical failure rates in the first week in children with AOM who are not treated with antibiotics. The pooled estimates indicate that a majority of these children have clinical resolution within the first week after presentation

2001 Health Technology Assessment (HTA) Database.

120. Management of acute otitis media

Management of acute otitis media Management of acute otitis media Management of acute otitis media Marcy M, Takata G, Chan L S Shekelle P, Mason W, Wachsman L, Ernst R, Hay J W, Corley P M, Morphew T, Ramicone E, Nicholson C Authors' objectives To analyse the evidence on the initial management of uncomplicated acute otitis media (AOM) in children, and to assess the following three questions. What is the natural history of AOM without antibiotic treatment? Are antibiotics effective in preventing (...) to establish differences in antibiotic efficacy. In addition, future studies should address the issue of bacterial resistance. Bibliographic details Marcy M, Takata G, Chan L S Shekelle P, Mason W, Wachsman L, Ernst R, Hay J W, Corley P M, Morphew T, Ramicone E, Nicholson C. Management of acute otitis media. Rockville, MD, USA: Agency for Healthcare Research and Quality. Evidence Report/Technology Assessment; 15. 2001 Original Paper URL Other publications of related interest Jadad AR, Moore RA, Carroll D

2001 DARE.